| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 02/03/2005 | WO2005009363A2 Treatment of pre-cancerous conditions and prevention of cancer using pcdgf-based therapies |
| 02/03/2005 | WO2005009355A2 Synergistic stimulation of the immune system using immunostimulatory oligonucleotides and/or immunomer compounds in conjunction with cytokines and/or chemotherapeutic agents or radiation therapy |
| 02/03/2005 | WO2005009346A2 Inhibition of gene function by delivery of polynucleotide-based gene expression inhibitors to mammalian cells in vivo |
| 02/03/2005 | WO2005009217A2 Diagnosis of pre-cancerous conditions using pcdgf agents |
| 02/03/2005 | WO2004100773A3 Diagnostic and therapeutic treatments related to mitochondrial disorders |
| 02/03/2005 | WO2004087959A3 Stat-6 gene variants and process of detecting the same |
| 02/03/2005 | WO2004081175A3 Methods and compositions for purification of nucleic acid from a host cell |
| 02/03/2005 | WO2004041196A3 Methods and compositions for the diagnosis of neuroendocrine lung cancer |
| 02/03/2005 | US20050028233 Plant fatty acid amide hydrolases |
| 02/03/2005 | US20050027130 Rhodamine dye compounds for patterns with DNA sequences for kits |
| 02/03/2005 | US20050027116 Includes a hydroxyl-containing compound bound to support by disiloxyl linkage; combinatorial chemistry; oligonucleotide biosynthesis |
| 02/03/2005 | US20050027115 Cationic lipid-mediated enhancement of nucleic acid immunization of cats |
| 02/03/2005 | US20050027109 Preparing genetically engineered therapeutic protein fusion comprised of antibody constant region for use in treatment of metabolic disorders |
| 02/03/2005 | US20050027103 Matrix protein for use diagnosis, treatment, and prevention of viral infections, cell proliferative and neurological disorders |
| 02/03/2005 | US20050026936 1,4-Dideoxy-1-C-(4-hydroxypyrrolo[3,2-d]pyrimidin-7-yl)-1,4-imino-D-ribitol derivatives or salts; parasite purine nucleoside, -hydrolase, -phosphorylase and/or phosphoribosyl transferase inhibitors; antiprotozoa, anticarcinogenic, antiinflammatory, and immunosuppressant agents; autoimmune diseases |
| 02/03/2005 | US20050026861 Modified dinucleotides for reduce or improve immunostimulatory; genetic vaccines; cancer vaccines |
| 02/03/2005 | US20050026858 Modified nucleotides for immunotherapy; induce immunology response; consisting of nucleoside methylphosphonate and 2'-O-methyl-ribonucleoside groups |
| 02/03/2005 | US20050026817 peptide nucleic acids used as gene expression inhibitors and as probes for detection of nucleic acids |
| 02/03/2005 | US20050026278 RNA interference mediating small RNA molecules |
| 02/03/2005 | US20050026252 Expression vector comprising rodent regulatory sequences for use as gene expression control tools in genetic engineering |
| 02/03/2005 | US20050026243 Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for the treatment of obesity and related disorders |
| 02/03/2005 | US20050026218 Expression vector comprising nucleotide sequences coding type IV secretion system proteins (T4SS) for use in identifying modulator for treatment of rickettsia infection |
| 02/03/2005 | US20050026198 Method of selecting an active oligonucleotide predictive model |
| 02/03/2005 | US20050026192 Oligonucleotide synthesis with alternative solvents |
| 02/03/2005 | US20050026191 Nucleotide sequences coding interferon-inducible proteins in fibroblasts for use in diagnosis, prevention and treatment of cell proliferative, nervous system, glandular and inflammatory diseases |
| 02/03/2005 | US20050026188 Methods of identifying, characterizing and comparing organism communities |
| 02/03/2005 | US20050026183 Using methylation patterns of guanine and cytosine dinucleotides as a diagnostic and/or prognostic indicator of cell proliferfative disorders; genomic imprinting control regions (ICRs) |
| 02/03/2005 | US20050026180 Direct multiplex characterization of genomic DNA |
| 02/03/2005 | US20050026178 Allosteric probes and methods |
| 02/03/2005 | US20050026169 Using presence of single nucleotide polymorphism in apopoliprotein gene sequences as diagnostic indicator of cardiovascular disorders |
| 02/03/2005 | US20050026167 Complete mitochondrial genome sequences as a diagnostic tool for the health sciences |
| 02/03/2005 | US20050026166 Using structure specific nucleases as diagnostic tools in detection of preferential nucleotide sequences; clinical microbiology, blood screening, food safety, genetic disease diagnosis and prognosis |
| 02/03/2005 | US20050026160 Compositions comprising alternating 2'-modified nucleosides for use in gene modulation |
| 02/03/2005 | US20050026157 Enzymatic fusion protein comprising cleavage and nuclear localization domain for use gene targeting tool in gene therapeutics |
| 02/03/2005 | US20050026149 Expression vector comprising chimeric nucleotide comprising nuclear, choloroplast and/or mitochondrial localization signals for use as tools in transfer of heterologous genes into preferential genomes |
| 02/03/2005 | US20050025815 Protonated/acidified nucleic acids are effective as bactericidal and/or bacteriostatic agents |
| 02/03/2005 | DE10328813A1 Verfahren zur Untersuchung von Cytosin-Methylierungen in DNA-Sequenzen mittels triplexbildender Oligomere A method for the examination of cytosine methylations in DNA sequences by means triplexbildender oligomers |
| 02/03/2005 | CA2533691A1 Thioaptamers enable discovery of physiological pathways and new therapeutic strategies |
| 02/03/2005 | CA2532939A1 Plant cell cycle genes and methods of use |
| 02/03/2005 | CA2532926A1 Combined use of immunostimulatory oligonucleotides and cytokines or radiation |
| 02/03/2005 | CA2532809A1 Plant centromere compositions |
| 02/03/2005 | CA2532430A1 Humanized versions of monoclonal antibody ds6 that bind tumour antigen ca6 |
| 02/03/2005 | CA2531492A1 Compositions for purifying and crystallizing molecules of interest |
| 02/03/2005 | CA2531105A1 Method and compositions for detection and enumeration of genetic variations |
| 02/03/2005 | CA2530178A1 Methods for generating or increasing revenues from crops |
| 02/03/2005 | CA2530085A1 Compositions and methods for the production of betaine lipids |
| 02/03/2005 | CA2528043A1 Marks as modifiers of the pten pathway and methods of use |
| 02/03/2005 | CA2527557A1 Genes encoding carotenoid compounds |
| 02/03/2005 | CA2526814A1 Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof |
| 02/02/2005 | EP1502110A2 Qm-7 and qt-6 cells transfected with mutant cell surface expressed channel receptors and assays using the transfected cells |
| 02/02/2005 | EP1501948A1 A dna enzyme to inhibit plasminogen activator inhibitor-1 |
| 02/02/2005 | EP1501942A2 Methods to identify evolutionarily significant changes in polynucleotide and polypeptide sequences in domesticated plants and animals |
| 02/02/2005 | EP1501935A2 Low-cost production of peptides |
| 02/02/2005 | EP1501930A2 Oligomeric compounds for the modulation hif-1alpha expression |
| 02/02/2005 | EP1501925A2 Identification of a phage associated lytic enzyme to rapidly and specifically detect and kill bacillus anthracis |
| 02/02/2005 | EP1501853A2 RNA INTERFERENCE MEDIATED INHIBITION OF EPIDERMAL GROWTH FACTOR RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 02/02/2005 | EP1501851A1 Process for preparing oligonucleotides |
| 02/02/2005 | EP1501848A1 Synthesis of locked nucleic acid derivatives |
| 02/02/2005 | EP1501842A2 Solid supports functionalised by phosphorus dendrimers, method for preparing same and uses thereof |
| 02/02/2005 | EP1501345A1 Regulated ethylene sensitivity to control flower longevity in a plant |
| 02/02/2005 | EP1266025A4 Protein scaffolds for antibody mimics and other binding proteins |
| 02/02/2005 | EP1246936A4 Classification and typing of prokaryotes using hyperpolymorphic simple sequence repeats |
| 02/02/2005 | EP1198584B1 Transcription-based gene mapping |
| 02/02/2005 | EP0741788B1 Inducing tolerance with tolerogenic fusion proteins |
| 02/02/2005 | EP0674650B1 Nucleic acid probes for lactobacillus detection |
| 02/02/2005 | CN1575181A Use of dinucleoside polyphosphate to stimulate removal of fluid in retinal disorders |
| 02/02/2005 | CN1572886A Method of detecting micrometastasis |
| 02/02/2005 | CN1572884A Modeling method for predicting a hepatitis B patient to response to interferon treatment and model thereof |
| 02/02/2005 | CN1572883A Determination of specificity for a segment of ureaplasma DNA sequence and use thereof |
| 02/02/2005 | CN1572875A Anti-SARS vaccine |
| 02/02/2005 | CN1572801A Double functional fusion protein possessing antineoplastic functions, method for making same and use thereof |
| 02/02/2005 | CN1572800A Specific antibody of tumor-associated antigen SM5-1 and use thereof |
| 02/02/2005 | CN1572797A Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 02/02/2005 | CN1572796A Method and apparatus for recovering nucleic acids |
| 02/02/2005 | CN1187450C Method for producing transgenic non-human mammal |
| 02/02/2005 | CN1187363C Covalently linked oligonucleotide minor groove binder conjugates |
| 02/02/2005 | CN1187362C Solid-phase nucleic acid isolation |
| 02/01/2005 | US6849745 Fluorescent dye for use in the detection of preferential compounds |
| 02/01/2005 | US6849726 Non-nucleotide containing RNA |
| 02/01/2005 | US6849723 Oligonucleotide analogs having modified dimers |
| 02/01/2005 | US6849612 Oligonucleotide modulation of cell adhesion |
| 02/01/2005 | US6849462 Producing arrays by depositing a resist on a substrate, removing a portion of the resist to expose localized areas, dispensing a monomer to occupy a localized area of the surface of the support, allowing the monomer to bind |
| 02/01/2005 | US6849431 Non-B, non-C, non-G hepatitis virus gene, polynucleotide, polypeptide, virus particle, method for isolating virus particle, and method for detecting virus |
| 02/01/2005 | US6849427 Dermatophagoides pteronyssinus proteins |
| 02/01/2005 | US6849410 Method for detecting DNA polymorphism applying triple strand DNA formation technique |
| 02/01/2005 | US6849407 Detection of varicella-zoster virus |
| 02/01/2005 | US6849398 For detecting cleavage or ligation reactions; particularly, invention relates to assays which employ substrates covalently linked both to solid phase matrix and to nucleotide strand encoded to identify substrate; includes pcr primer sequences |
| 02/01/2005 | US6849397 Classifying organism; obtain sample, incubate with surface plasmon resonance substrate, analyze nucleotide sequences immobilized on the substrate, classify |
| 02/01/2005 | US6849261 CD4-independent HIV envelope proteins as vaccines and therapeutics |
| 01/27/2005 | WO2005007877A2 Regulatable promoters for synthesis of small hairpin rna |
| 01/27/2005 | WO2005007875A2 Enhanced promoters for synthesis of small hairpin rna |
| 01/27/2005 | WO2005007871A2 Genetic marker of response to atypical antipsychotics and antidepressants and methods for use thereof |
| 01/27/2005 | WO2005007867A2 Thermostable amylase polypeptides, nucleic acids encoding those polypeptides and uses thereof |
| 01/27/2005 | WO2005007852A2 Room temperature elution of nucleic acids |
| 01/27/2005 | WO2005007829A2 Materials and methods for the modulation of cyclin-dependent kinase inhibitor-like polypeptides in maize |
| 01/27/2005 | WO2005007825A2 Modulation of aminopeptidase n expression |
| 01/27/2005 | WO2005007823A2 Compositions, kits, and methods for stimulation of homologous recombination |
| 01/27/2005 | WO2005007818A2 Exo-specific amylase polypeptides, nucleic acids encoding those polypeptides and uses thereof |
| 01/27/2005 | WO2005007815A2 Hairpin-labeled probes and methods of use |
| 01/27/2005 | WO2005007808A2 Hiv polynucleotides and polypeptides derived from botswana mj4 |